Form D · Biotechnology
AFRAXIS, INC.
San Diego, CA · CIK 0001435673
Offering snapshot reported Apr 3, 2012 · SEC filing
- Reported sold
- $45K Offering amount: $45K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2012 | Initial | $45,000 | No comparison | 1 | SEC filing |
| Dec 21, 2011 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Feb 15, 2011 | Initial | $650,000 | No comparison | 1 | SEC filing |
| May 13, 2010 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
| Jun 9, 2009 | Initial | $750,001 | No comparison | 1 | SEC filing |
| Sep 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176059
Source: Form D, filed Apr 3, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Braden Bohrman | Director |
| Braden Bohrmann | Director |
| David Campbell | Executive |
| Doug Downs | Executive |
| Douglas Downs | Executive |
| Steve Heinemann | Director |
| Steve Heinemann, Ph.D | Director |
| Jay B. Lichter | Director, Executive |
| Court Turner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11099 N. Torrey Pines Road Suite 290
San Diego, CA, 92037
San Diego, CA, 92037